Medtech start-up Gendius, based at Alderley Park in Cheshire, has signed a memorandum of understanding with Macclesfield pharmaceuticals firm AstraZeneca to deliver its diabetes management platform in the Middle East.
Through the partnership, healthcare professionals in the Middle East’s Gulf region can use Gendius’ Intellin diabetes management platform to help patients manage their condition. Countries in the region have some of the highest per capita rates of diabetes in the world, but careful management can reduce the risk of complications including cardiovascular and kidney disease, blindness and amputation.
Rory Cameron, chief executive at the medtech start-up Gendius said:
Diabetes is an increasing health and economic burden across the Gulf region, but effective diabetes management has huge scope for reducing that burden.
“Our Intellin technology platform is going to sit at the centre of this programme, and we are hugely excited to be bringing our innovative technology directly to GCC [Gulf Cooperation Council] healthcare professionals and patients.”
The Intellin software allows users to monitor their health with minimal manual input, by synchronising with data from other apps and wearable technology such as FitBit smart watches.
The medtech start-up’s partnership with AstraZeneca is part of the pharmaceutical firm’s framwork to create integrated science ecosystems through local bio-hubs across the world: the Emerging Markets Health Innovation Hubs initiative.
Aleksandr Bedenkov, MD, PhD and Vice President Medical International at AstraZeneca, said,
Our Health Innovation Hubs in Emerging Markets improve local capacity for R&D to address local needs and reinforce our commitment to create and strengthen partnerships across emerging biomedical clusters to accelerate innovation, increase healthcare access and improve outcomes for society and patients. The establishment of our GCC hub marks the first launch in the Middle East to complement our existing network of eight other hubs across Emerging Markets, boosting the capabilities to provide world-leading services to their patients. We are very excited about this collaboration that will support diabetes patients and facilitate the disease management.”
MAG subsidiary acquires European airport parking marketplace 
North West Hydrogen industry gears up for third annual Hydrogen Week 
Female Founders Incubator launches at Alderley Park